Nisa Investment Advisors’s CureVac CVAC Stock Holding History

Nisa Investment Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,602	Closed	-$88	–	2264
2021 Q3	$88	Buy	+1,602	New	+$96.5K	﹤0.01%	1756

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Nisa Investment Advisors's CVAC Position: Q4 2021 in Review

Nisa Investment Advisors sold out of CureVac (CVAC) in Q4 2021, closing a stake of 1,602 shares — an estimated $88 sold.

Nisa Investment Advisors first reported a position in CVAC in Q3 2021 and held it in 1 quarter. The position peaked at $88 in Q3 2021. 103 funds tracked by Wall St. Rank hold CVAC as of Q4 2021.

Nisa Investment Advisors reported no remaining CureVac position as of Q4 2021 after selling out during the quarter.
Nisa Investment Advisors sold 1,602 CureVac shares in Q4 2021, an estimated $88.
Nisa Investment Advisors first reported a position in CureVac in Q3 2021 and held it in 1 quarter.
Nisa Investment Advisors's CureVac position peaked at $88 in Q3 2021.
103 funds tracked by Wall St. Rank held CureVac as of Q4 2021.

Based on Nisa Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.